Acute Myeloid Leukemia (AML) in Remission
Oncology·MeSH: Leukemia, Myeloid, Acute
Prevalence
6.0 / 100K
Incidence
4.3 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Acute Myeloid Leukemia (AML) in Remission?
There are 1 clinical trial targeting Acute Myeloid Leukemia (AML) in Remission tracked by BioSniper.
What is the prevalence of Acute Myeloid Leukemia (AML) in Remission?
The estimated prevalence of Acute Myeloid Leukemia (AML) in Remission is approximately 6.0 per 100,000 population.
Deep-dive into Acute Myeloid Leukemia (AML) in Remission
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis